Search for Clinical Trial Results
Carcinoma, Medullary - 25 Studies Found
| Status | Study |
| Terminated |
Study Name: Clinical Evaluation of 18F-DOPA Positron Emission Tomography in Medullary Thyroid Cancer Condition:
|
| Completed |
Study Name: Sunitinib Malate in Treating Patients With Iodine-Refractory Recurrent or Metastatic Thyroid Cancer Condition:
|
| Recruiting |
Study Name: Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer Condition:
Interventions: Drug: Pazopanib Hydrochloride Given PO Other Names: |
| Completed |
Study Name: Tanespimycin in Treating Patients With Inoperable Locoregionally Advanced or Metastatic Thyroid Cancer Condition:
Interventions: |
| Active, not recruiting |
Study Name: Sunitinib in Treating Patients With Thyroid Cancer That Did Not Respond to Iodine I 131 and Cannot Be Removed by Surgery Condition:
Interventions: |
| Not yet recruiting |
Study Name: Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor Condition:
|
| Active, not recruiting |
Study Name: Cabozantinib S-Malate in Treating Younger Patients With Recurrent or Refractory Solid Tumors Condition:
|
| Completed |
Study Name: Suberoylanilide Hydroxamic Acid in Treating Patients With Metastatic and/or Locally Advanced or Locally Recurrent Thyroid Cancer Condition:
|